arrow
Back
A

Abdulrazzak Zarifa

university of texas system

11H-index
42Paper Count
472Citation Count
Published Papers 17
Publication Date
Biomarker study of pembrolizumab in patients with advanced rare cancers
err2026-06-16
err0
errOAAI
errAung Naing; Xiqi Li; Qi Wang; Xiangjun (Jun) Tian; Sharjeel Sabir; Priya R. Bhosale; Mohamed H. Derbala; Bettzy Stephen; Mingxuan Xu; Joud Hajjar; Serdar A. Gurses; Yali Yang; Hassan Ahmed Momin; Ignacio Ivan Wistuba; Anas Alshawa; Kenna R. Shaw; Abdulrazzak Zarifa; Gopal Singh; Renganayaki Krishna Pandurengan; Gabriela Maria Raso
errShare
errSave
Autoantibody profiling to predict response to the anti-PD-1 therapy, pembrolizumab, in rare tumors
err2025-08-05
err0
errOAAI
errM.H. Derbala; J. Hajjar; B. Stephen; S.A. Gurses; E. Kwiatkowski; P. Budde; H.-D. Zucht; M. Bräutigam; A.-S. Lindemann; B.A. Abhari; M.A. Gouda; L. Castillo; A. Zarifa; J.A. How; E. Rodriguez; J.T. Moyers; D.S. Hong; S. Fu; F. Meric-Bernstam; A. Naing
errShare
errSave
A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies
err2025-03-01
err0
PREAI
errAhmed, Jibran; Knisely, Anne; Torrado, Carlos; Stephen, Bettzy; Yang, Yali; Song, Juhee; Alshawa, Anas; Zarifa, Abdulrazzak; Jhingran, Anuja; Koay, Eugene J.; Morris, Van Karlyle; Javle, Milind; Wolff, Robert A.; Meric-Bernstam, Funda; Pant, Shubham; Rodon, Jordi; Naing, Aung
errShare
errSave
Autoantibody profiling for predictive biomarkers for immune-related adverse events and clinical benefit in rare tumors treated with anti-PD-1 therapy
err2024-03-22
err0
PREAI
errDerbala, Mohamed H.; Hajjar, Joud; Stephen, Bettzy; Gurses, Serdar A.; Kwiatkowski, Evan; Budde, Petra; Zucht, Hans-Dieter; Brautigam, Manuel; Schubert, Ann-Sophie; Ahangarianabhari, Behnaz; Rodriguez, Enedelia; Gouda, Mohamed; Castillo, Lilibeth; Zarifa, Abdulrazzak; How, Jeffrey A.; Moyers, Justin T.; Hong, David S.; Meric-Bernstam, Funda; Naing, Aung
errShare
errSave
Phase 1/2 trial of avelumab combined with utomilumab (4-1BB agonist), PF-04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies
errCANCER
IF5.1
err2023-10-21
err6
PREAI
errKnisely, Anne; Ahmed, Jibran; Stephen, Bettzy; Piha-Paul, Sarina A.; Karp, Daniel; Zarifa, Abdulrazzak; Fu, Siqing; Hong, David Sanghyun; Rodon Ahnert, Jordi; Yap, Timothy A.; Tsimberidou, Apostolia M.; Alshawa, Anas; Dumbrava, Ecaterina E.; Yang, Yali; Song, Juhee; Meric-Bernstam, Funda; Jazaeri, Amir A.; Naing, Aung
errShare
errSave
Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort study
errCANCER
IF5.1
err2022-04-22
err9
errOAAI
errSheshadri, Ajay; Goizueta, Alberto A.; Shannon, Vickie R.; London, David; Garcia-Manero, Guillermo; Kantarjian, Hagop M.; Ravandi-Kashani, Farhad; Kadia, Tapan M.; Konopleva, Marina Y.; DiNardo, Courtney D.; Pierce, Sherry; Zarifa, Abdulrazzak; Albittar, Aya A.; Zhong, Linda L.; Akhmedzhanov, Fechukwu O.; Arain, Muhammad H.; Alfayez, Mansour; Alotaibi, Ahmad; Altan, Mehmet; Naing, Aung; Mendoza, Tito R.; Godoy, Myrna C. B.; Shroff, Girish; Kim, Sang T.; Faiz, Saadia A.; Kontoyiannis, Dimitrios P.; Khawaja, Fareed; Jennings, Kristofer; Daver, Naval G.
errShare
errSave
Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study (vol 39, pg 1357, 2021)
err2021-10-27
err1
errOAAI
errThein, Kyaw Zin; Piha-Paul, Sarina A.; Tsimberidou, Apostolia; Karp, Daniel D.; Janku, Filip; Zarifa, Abdulrazzak; Shah, Jatin; Milton, Denai R.; Bean, Stacie; McQuinn, Lacey; Gong, Jing; Colen, Rivka; Carter, Brett W.; Subbiah, Vivek; Ogbonna, Deby C.; Pant, Shubham; Meric-Bernstam, Funda; Naing, Aung
errShare
errSave
Supportive care for the prevention of nausea, vomiting and anorexia in a phase 1B study of selinexor in advanced cancer patients: an exploratory study
err2021-09-24
err4
PREAI
errDev, Rony; Zhong, Linda L.; Zarifa, Abdulrazzak; Albittar, Aya A.; Rubin, Laura; Liu, Suyu; Yap, Timothy A.; Dalal, Shalini; Hui, David; Karp, Daniel D.; Tsimberidou, Apostolia M.; Piha-Paul, Sarina A.; Ahnert, Jordi Rodon; Fu, Siqing; Meric-Bernstam, Funda; Naing, Aung
errShare
errSave
Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study
err2021-04-28
err7
errOAAI
errThein, Kyaw Zin; Piha-Paul, Sarina A.; Tsimberidou, Apostolia; Karp, Daniel D.; Janku, Filip; Zarifa, Abdulrazzak; Shah, Jatin; Milton, Denai R.; Bean, Stacie; McQuinn, Lacey; Gong, Jing; Colen, Rivka; Carter, Brett W.; Subbiah, Vivek; Ogbonna, Deby C.; Pant, Shubham; Meric-Bernstam, Funda; Naing, Aung
errShare
errSave
Associations between the gut microbiome and fatigue in cancer patients
err2021-03-12
err30
errOAAI
errHajjar, Joud; Mendoza, Tito; Zhang, Liangliang; Fu, Siqing; Piha-Paul, Sarina A.; Hong, David S.; Janku, Filip; Karp, Daniel D.; Ballhausen, Alexej; Gong, Jing; Zarifa, Abdulrazzak; Peterson, Christine B.; Meric-Bernstam, Funda; Jenq, Robert; Naing, Aung
errShare
errSave
Effects of glutamine for prevention of radiation-induced esophagitis: a double-blind placebo-controlled trial
err2021-02-13
err4
PREAI
errAlshawa, Anas; Cadena, Alexandra Perez; Stephen, Bettzy; Reddy, Akhila; Mendoza, Tito R.; McQuinn, Lacey; Lawhorn, Kristie; Zarifa, Abdulrazzak; Bernhardt, Alexander Maximilian; Fessaheye, Senait; Warneke, Carla L.; Chang, Joe Y.; Naing, Aung
errShare
errSave
Cardiac Toxicities Associated with Immune Checkpoints Inhibitors: Mechanisms, Manifestations and Management
err2021-01-01
err8
errOAAI
errZarifa, Abdulrazzak; Kim, Jin Wan; Lopez-Mattei, Juan; Palaskas, Nicolas; Iliescu, Cezar; Kim, Peter Y.
errShare
errSave
Selinexor in combination with carboplatin and pemetrexed (CP) in patients with advanced or metastatic solid tumors: Results of an open label, single-center, multi-arm phase Ib study
err2020-11-01
err0
errOAAI
errThein, K. Z.; Tsimberidou, A. M.; Piha-Paul, S. A.; Janku, F.; Karp, D. D.; Fu, S.; Zarifa, A.; Gong, J.; Yap, T. A.; Hong, D. S.; Subbiah, V.; Pant, S.; Meric-Bernstam, F.; Naing, A.
errShare
errSave
Selinexor in combination with standard chemotherapy in patients with advanced solid tumours: Results of an open label, single-center, multi-arm phase Ib study
err2020-11-01
err0
errOAAI
errThein, K. Z.; Tsimberidou, A. M.; Piha-Paul, S. A.; Janku, F.; Karp, D. D.; Fu, S.; Zarifa, A.; Gong, J.; Hong, D. S.; Yap, T. A.; Subbiah, V.; Pant, S.; Meric-Bernstam, F.; Naing, A.
errShare
errSave
Selinexor in combination with topotecan in patients with advanced or metastatic solid tumours: Results of an open label, single-center, multi-arm phase Ib study
err2020-09-01
err1
errOAAI
errThein, K. Z.; Tsimberidou, A. M.; Piha-Paul, S.; Janku, F.; Karp, D. D.; Fu, S.; Zarifa, A.; Gong, J.; Hong, D. S.; Yap, T. A.; Subbiah, V.; Pant, S.; Meric-Bernstam, F.; Naing, A.
errShare
errSave
Selinexor in combination with carboplatin and paclitaxel in patients with advanced or metastatic solid tumours: Results of an open label, single-center, multi-arm phase Ib study
err2020-09-01
err1
errOAAI
errThein, K. Z.; Tsimberidou, A. M.; Piha-Paul, S.; Janku, F.; Karp, D. D.; Fu, S.; Zarifa, A.; Gong, J.; Yap, T. A.; Hong, D. S.; Subbiah, V.; Pant, S.; Meric-Bernstam, F.; Naing, A.
errShare
errSave
Phase Ib study to evaluate the safety of selinexor (SEL) in combination with pembrolizumab (PEM) in patients with advanced malignancies- the: The melanoma experience
err2020-09-01
err2
errOAAI
errGlitza, I. C.; Patel, S.; Zarifa, A.; Leung, C. H.; Lin, H.; McQuinn, L.; Gong, J.; Yilmaz, B.; Chambers, J.; Sulovic, S.; John, I.; Hennegan, T.; Fu, S.; Tsimberidou, A. M.; Janku, F.; Karp, D. D.; Meric-Bernstam, F.; Naing, A.
errShare
errSave